Prevalence of Ile-460-Val/ParE substitution in clinical Streptococcus pneumoniae isolates that were less susceptible to fluoroquinolones

Current Microbiology

Volumn 51, Issue 1, 2005, Pages 27-30

  Kawamura Sato, Kumiko ^a,b   Hasegawa, Tadao ^b   Torii, Keizo ^b   Ito, Hideo ^a   Ohta, Michio ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; FLEROXACIN; GATIFLOXACIN; GLYCINE; GREPAFLOXACIN; ISOLEUCINE; LEVOFLOXACIN; LOMEFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; SPARFLOXACIN; TOSUFLOXACIN; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SUBSTITUTION; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 23844465952     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-005-4439-3     Document Type: Article

References (11)

1. TA Davies GA Pankuch BE Dewasse MR Jacobs PC Appelbaum 1999 In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae Antimicrob Agents Chemother 43 1177 1182
2. MJ Gill NP Brenwald R Wise 1999 Identification of an efflux pump gene, pmrA, associated with fluoroquinoline resistance in Streptococcus pneumoniae Antimicrob Agents Chemother 43 187 189
3. ME Jones DF Sahm N Martin S Scheuring P Heisig C Thornsberry K Kohrer F-J Schmitz 2000 Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoro-quinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season Antimicrob Agents Chemother 44 462 466
4. JA Karlowsky C Thornsberry ME Jones AT Evangelista IA Critchley DF Sahm 2003 Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST surveillance program (1998-2002) Clin Infect Dis 36 963 970
5. National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. M100-S11. National Committee for Clinical Laboratory Standards, Wayne, PA
6. X-S Pan J Ambler S Mehtar LM Fisher 1996 Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae Antimicrob Agents Chemother 40 2321 2326
7. B Perichon J Tankovic P Courvalin 1997 Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae Antimicrob Agents Chemother 41 1166 1167
8. LJV Piddock MM Johnson S Simjee L Pumbw 2002 Expression of efflux pump gene pmrA in fluoroquinolone-resistant and susceptible clinical isolates of Streptococcus pneumoniae Antimicrob Agents Chemother 46 808 812
9. F Sifaoui V Lamour E Varon D Moras L Gutmann 2003 ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae J Bacteriol 185 6137 6146
10. J Tankovic B Perichon J Duval P Courvalin 1996 Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro Antimicrob Agents Chemother 40 2505 2510
11. LM Weigel GJ Anderson RR Facklam FC Tenover 2001 Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae Antimicrob Agents Chemother 45 3517 3523